Sionna's early investors included the Cystic Fibrosis Foundation, which CEO Mike Cloonan said has been helpful as the company prepares to navigate the regulatory process. (Getty/LIgorko) After ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Ongoing PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis is on track with topline data anticipated ...
Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results